NCT05380388View on ClinicalTrials.gov

A Safety, Immunogenicity and Efficacy Study of PvRII/Matrix-M in Healthy Thai Adults Living in Thailand ( MIST3 )

PHASE2Not yet recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

December 1, 2025

Primary Completion Date

December 30, 2027

Study Completion Date

December 30, 2027

Conditions

Plasmodium Vivax InfectionMalaria Vaccine

Interventions

BIOLOGICAL

Malaria Vaccine

blood stage Plasmodium vivax malaria vaccine

BIOLOGICAL

HBV vaccine

HBV Vaccine

Trial Locations (1)

10400

Faculty of Tropical Medicine, Bangkok

All Listed Sponsors

collaborator

Mahidol University

OTHER

lead

University of Oxford

OTHER

NCT05380388 - A Safety, Immunogenicity and Efficacy Study of PvRII/Matrix-M in Healthy Thai Adults Living in Thailand ( MIST3 ) | Biotech Hunter | Biotech Hunter